Related Experiment Video

Updated: Oct 10, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Natural history of cardiac involvement in myotonic dystrophy: correlation with CTG repeats

G Antonini1, F Giubilei, A Mammarella

  • 1(Department of Neurological Sciences, University of Rome, La Sapienza, Italy. antoninimusc@uniroma1.it

Neurology
|November 9, 2000
PubMed

Insights

In myotonic dystrophy patients, cardiac complications occurred in 38%. Longer cytosine-thymine-guanine (CTG) gene expansions were linked to earlier onset of EKG abnormalities, influencing cardiac complication timing.

Area of Science:

  • Cardiology
  • Genetics
  • Neuromuscular Disorders

Background:

  • Myotonic dystrophy is a multisystem disorder with significant cardiac involvement.
  • Cardiac complications, such as arrhythmias and conduction defects, are a major cause of morbidity and mortality in myotonic dystrophy.
  • The relationship between the genetic defect, specifically cytosine-thymine-guanine (CTG) repeat expansion, and the development of cardiac issues requires further elucidation.

Purpose of the Study:

  • To prospectively investigate the natural course of cardiac involvement in patients with myotonic dystrophy.
  • To examine the relationship between the length of CTG repeat expansion and the development and timing of cardiac complications.

Main Methods:

  • Prospective study of 50 patients diagnosed with myotonic dystrophy.
  • Regular cardiovascular evaluations including electrocardiogram (EKG) and EKG-Holter monitoring.
  • Median follow-up duration of 56 months.
  • Correlation analysis between CTG repeat length and cardiac event occurrence and timing.

Main Results:

  • Nineteen patients (38%) experienced major EKG abnormalities during the follow-up period.
  • No significant correlation was found between CTG repeat length and the frequency of EKG abnormalities.
  • A significant inverse correlation was observed between CTG repeat length and the age of onset for EKG abnormalities (p < 0.0001).

Conclusions:

  • CTG repeat length is a critical factor influencing the timing of cardiac complications in myotonic dystrophy.
  • Earlier onset of cardiac issues is associated with longer CTG expansions, even if the overall frequency of abnormalities is not directly correlated.
  • These findings highlight the importance of genetic factors in predicting the temporal progression of cardiac involvement in myotonic dystrophy.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...